April 13, 2016
-First and only blood-based colorectal cancer screening test approved by the FDA -Innovative, convenient and effective screening option for millions of eligible Americans -Commercialization initiated with […]
March 31, 2016
Seattle-based Clinical Research Organization is Awarded a National Cancer Institute (NCI) Contract for Oncology Biospecimen Collection SEATTLE, March 30, 2016 Global BioClinical (GBC), http://www.globalbioclinical.com, is pleased to […]
March 24, 2016
Curetis to Launch CE-IVD Unyvero Blood Culture Application Cartridge at ECCMID 2016 – Successful completion of CE Performance Evaluation Study – Covers 103 diagnostic targets with […]
March 6, 2016
Curetis Validating Blood Culture Cartridge for CE-IVD Launch in Q2 Mar 03, 2016 NEW YORK (GenomeWeb) – In preparation for a CE-IVD launch in the second […]
February 23, 2016
Curetis Starts Final Validation Study for New Unyvero Blood Culture Application Cartridge – Data and CE-IVD launch expected in Q2, 2016 – Company also prepares launch […]
February 3, 2016
Curetis Expands Commercial Team – Company hires Willem Haagmans as Head of Sales EMEA – Amsterdam, the Netherlands and Holzgerlingen, Germany, February 3, 2016 — Curetis […]
January 12, 2016
Curetis Establishes Medical Advisory Board with Internationally Renowned Experts Curetis AG, 11 Jan 16, Amsterdam, The Netherlands, and Holzgerlingen, Germany, January 11, 2016 – Curetis N.V., a […]
January 8, 2016
Epigenomics Receives FDA Notification About Status of Pending Approval Decision for Epi proColon® Berlin, Germany, January 8, 2016 – Epigenomics AG, Berlin, Germany, (Frankfurt Prime Standard: […]
November 10, 2015
Curetis AG / Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million . Holzgerlingen, Germany, November 10, 2015 — Curetis N.V.[1] (the “Company” […]
